NanoEcho is featured in an article published by Affärsvärlden! In the interview with Linda Persson, you can read about NanoEcho and the ongoing emission.
‘Our technology has several advantages. We address an issue with inadequate diagnostics, which means less suffering for the patient and lower costs for healthcare,’ says Linda Persson.
Read the full article here: https://www.affarsvarlden.se/artikel/nanoecho-noteras-pa-nasdaq-first-north-tar-in-30-miljoner
NanoEcho’s innovative method, with its high precision, aims to facilitate the differentiation between diseased and healthy tissue and at the same time determine a more precise localization of cancerous tissue. The goal is to provide a more reliable diagnosis of, for example cancer diseases, that has the potential to contribute to cost-effectiveness in the health care.
Not For Sale – For Clinical Investigation Use Only – EU Trial No.: 2024-515335-29-00